The effects of calcium sodium ethylenediaminetetra-acetate (CaNa2EDTA) on the kinetics of distribution and excretion of lead (210Pb) have been studied in rats. When the chelant was given intravenously, at 50 mg./rat daily after a single intravenous injection of 100 μg. lead/rat, it greatly increased the urinary excretion of lead but reduced the faecal excretion. The greatest effects occurred in the rats treated with chelant shortly after the lead injection. When the chelant was given seven or more days after the lead the increase in lead excretion was negligible. CaNa2EDTA mobilized lead from every tissue, but the kinetic analysis of the disappearance of 210Pb showed the presence of two elimination phases. Lead ions weakly bound to the cells were rapidly removed by EDTA, whereas the lead fixed to endocellular constituents was only slowly removed. The chelant did not mobilize lead from bone.
Probably CaNa2EDTA entered the extravascular space but not the cells. Hence it only accelerated the passage of lead from the cells by lowering the concentration of lead outside them.
210Pb was also given orally in doses of 500 μg. lead/rat. About 18% of the dose was absorbed through the intestine to be distributed in all tissues. Rats treated orally with CaNa2EDTA showed an increase in urinary lead excretion and a reduction in lead fixed in the body.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.